$SSII News

LUCID CAPITAL MARKETS Initiates Coverage On SS Innovations Intl with Buy Rating, Announces Price Target of $7

SS Innovations International COO, CFO Milan Rao Steps Down, Effective May 25

SS Innovations Reports First Quarter 2026 Financial Results

SS Innovations Q1 EPS $(0.02) Up From $(0.03) YoY, Sales $11.101M Up From $5.100M YoY

SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress

SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System

SS Innovations International Files Prospectus To Offer Up To $150M In Securities

SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026

SS Innovations: Progress Is Real, But I Still See Limited Upside

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

SS Innovations International, Inc. (SSII) Gains Approvals for SSi Mantra in Key Emerging Markets

SS Innovations Is A Compelling Surgical Robotics Growth Play

SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya

SS Innovations Expands Regulatory Approval Of SSi Mantra Surgical Robotic System In Colombia, Oman, Sri Lanka, And Kenya

SS Innovations Expands Regulatory Approval Of SSi Mantra Surgical Robotic System In Colombia, Oman, Sri Lanka, And Kenya

SS Innovations ramps up in telesurgery; XCath robot treats stroke remotely

Why SS Innovations (SSII) Is Up 10.8% After Telesurgery Milestone And Auditor Going Concern Doubts

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines

SS Innovations International Announces Telesurgery Approval For Its SSi Mantra Surgical Robotic System In Indonesia And The Phillipines

SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results